What Happened?
Cranbury, NJ-based Outlook-Therapeutics Appointed Alicia Tozier as Senior Vice President of Marketing and Market Access
About the Company
Oncobiologics, Inc. has changed its name to Outlook Therapeutics, Inc. Outlook Therapeutics is a clinical-stage biopharmaceutical company focused on developing its lead clinical program, ONS-5010, a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration (wet AMD). ONS-5010 is currently in its first clinical trial, which is being conducted outside of the U.S. and is designed to serve as the first of two adequate and well controlled studies for wet AMD.
About the Person
Alicia Tozier is Senior Vice President of Marketing and Market Access at Outlook Therapeutics. Previously, Alicia held various senior HR leadership roles in the industry.
Info Source
News
Short Profile